Novo Nordisk Adr stock is traded at $41.63, with a volume of 11,680,589. It is up +2.41% in the last 24 hours and up +9.38% over the past month. With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Previous Close:
$40.65
Open:
$40.97
24h Volume:
11,680,589
Relative Volume:
0.87
Market Cap:
$183.52B
Revenue:
$50.91B
Net Income/Loss:
$18.95B
P/E Ratio:
9.77
EPS:
$4.26
Net Cash Flow:
$1.92B
1W Performance:
+3.27%
1M Performance:
+9.38%
6M Performance:
-11.58%
1Y Performance:
-15.32%
1-Day Range:
$40.64$41.80
1-Week Range:
$40.08$41.80
52-Week Range:
$35.12$64.16
Novo Nordisk Adr Stock (NVO) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS